FBP1 and neoplasm: EZH2-mediated promoter hypermethylation represses FBP1, while FBP1 itself inhibits PRC2 activity through direct interaction with EZH2—a tumor-suppressive feedback loop disrupted by genotoxic agents that stabilize EZH2.